In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Avon looks into allegations in China

This article was originally published in The Rose Sheet

Executive Summary

Avon notifies Securities and Exchange Commission and U.S. Department of Justice that it is conducting voluntary internal investigation of its China operations, under the oversight of its Audit Committee, with focus on compliance with Foreign Corrupt Practices Act, according to Oct. 20 release. Investigation launched in June following receipt of allegation that "certain travel, entertainment and other expenses may have been improperly incurred in connection with the company's China operations," firm says. "Investigation is in its early stage, and no conclusion can be drawn at this time as to its outcome," says Avon

Avon notifies Securities and Exchange Commission and U.S. Department of Justice that it is conducting voluntary internal investigation of its China operations, under the oversight of its Audit Committee, with focus on compliance with Foreign Corrupt Practices Act, according to Oct. 20 release. Investigation launched in June following receipt of allegation that "certain travel, entertainment and other expenses may have been improperly incurred in connection with the company's China operations," firm says. "Investigation is in its early stage, and no conclusion can be drawn at this time as to its outcome," says Avon.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015739

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel